Physician profile
Nancy Liu
NPI 1992706816
$1,984.27
in general payments reported to CMS, 2019-2025
19 companies · $89.61 in 2025
The $89.61 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.51 · 2020: $202 · 2021: $762 · 2022: $758 · 2023: $88.86 · 2024: $51.60 · 2025: $89.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.18 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $632.10 | 2022 | |
| Welch Allyn | $632.10 | 2021 | |
| Amgen INC. | $142.20 | 2020-2025 | Otezla, Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $94.01 | 2021-2025 | Farxiga, Airsupra |
| Allergan, INC. | $78.11 | 2020 | |
| Esperion Therapeutics, INC. | $61.32 | 2020-2024 | Nexletol |
| Lilly USA, LLC | $46.71 | 2021-2024 | Mounjaro |
| Novo Nordisk INC | $37.11 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $36.42 | 2019-2021 | |
| Daiichi Sankyo INC. | $34.88 | 2021 | |
| Pfizer INC. | $34.28 | 2021-2023 | |
| Abbvie INC. | $33.03 | 2021 | |
| Eisai INC. | $26.82 | 2025 | |
| Amarin Pharma, INC. | $19.65 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.85 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.74 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.06 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.24 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.